These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25437042)

  • 1. Can we prevent antimicrobial resistance by using antimicrobials better?
    Soothill G; Hu Y; Coates A
    Pathogens; 2013 Jun; 2(2):422-35. PubMed ID: 25437042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and transmission of antimicrobial resistance among Gram-negative bacteria in animals and their public health impact.
    Mukerji S; O'Dea M; Barton M; Kirkwood R; Lee T; Abraham S
    Essays Biochem; 2017 Feb; 61(1):23-35. PubMed ID: 28258227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials.
    Thabit AK; Crandon JL; Nicolau DP
    Expert Opin Pharmacother; 2015 Feb; 16(2):159-77. PubMed ID: 25496207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Will new antimicrobials overcome resistance among Gram-negatives?
    Bassetti M; Ginocchio F; Mikulska M; Taramasso L; Giacobbe DR
    Expert Rev Anti Infect Ther; 2011 Oct; 9(10):909-22. PubMed ID: 21973303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting and preventing antimicrobial resistance utilizing pharmacodynamics: Part I gram positive bacteria.
    Linder KE; Nicolau DP; Nailor MD
    Expert Opin Drug Metab Toxicol; 2016; 12(3):267-80. PubMed ID: 26751348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistant gram-negative bacilli: A neglected healthcare crisis?
    Lautenbach E; Polk RE
    Am J Health Syst Pharm; 2007 Dec; 64(23 Suppl 14):S3-21; quiz S22-4. PubMed ID: 18029939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge.
    Unemo M
    BMC Infect Dis; 2015 Aug; 15():364. PubMed ID: 26293005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobials in small-scale urban pig farming in a lower middle-income country - arbitrary use and high resistance levels.
    Ström G; Boqvist S; Albihn A; Fernström LL; Andersson Djurfeldt A; Sokerya S; Sothyra T; Magnusson U
    Antimicrob Resist Infect Control; 2018; 7():35. PubMed ID: 29541447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial Resistance: a One Health Perspective.
    McEwen SA; Collignon PJ
    Microbiol Spectr; 2018 Mar; 6(2):. PubMed ID: 29600770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrolide resistance: an increasing concern for treatment failure in children.
    Jacobs MR; Johnson CE
    Pediatr Infect Dis J; 2003 Aug; 22(8 Suppl):S131-8. PubMed ID: 14566999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 15. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.
    Medina E; Pieper DH
    Curr Top Microbiol Immunol; 2016; 398():3-33. PubMed ID: 27406189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Arsenal of Multiple Antimicrobial Resistance, Toxins, and Virulence Factors in Gram-Negative Bacterial Isolates from Food - A Formidable Combination!
    Alemu A; Girma S; Mariam SH
    Infect Drug Resist; 2023; 16():1029-1037. PubMed ID: 36845021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circumventing antimicrobial-resistance and preventing its development in novel, bacterial infection-control strategies.
    Yu T; Jiang G; Gao R; Chen G; Ren Y; Liu J; van der Mei HC; Busscher HJ
    Expert Opin Drug Deliv; 2020 Aug; 17(8):1151-1164. PubMed ID: 32510243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Antimicrobial Agents for Gram-Negative Pathogens.
    Karvouniaris M; Almyroudi MP; Abdul-Aziz MH; Blot S; Paramythiotou E; Tsigou E; Koulenti D
    Antibiotics (Basel); 2023 Apr; 12(4):. PubMed ID: 37107124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antimicrobial Susceptibility of Pathogenic Gram-positive Anaerobic Cocci: Data of a University Hospital in Turkey].
    Akgül Ö; Söyletir G; Ülger Toprak N
    Mikrobiyol Bul; 2020 Jul; 54(3):404-417. PubMed ID: 32755517
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.